Diabetic foot ulcers are usually discussed in terms of wounds, infection and limb loss. A growing body of research shows that they are also a marker of survival. Understanding mortality after a diabetic foot ulcer (DFU) or lower-extremity amputation matters clinically because it reframes the foot as a window into a patient’s overall cardiovascular, renal and systemic health.
How High Is Mortality After a Diabetic Foot Ulcer?
Mortality estimates vary with the population studied and the era of the data, but they are consistently high. A systematic review by Jupiter and colleagues in International Wound Journal (2016) found that five-year mortality after ulceration was around 40%, with individual cohorts reporting figures from about 27% to more than 50%. Because the included studies were heterogeneous, the authors did not pool the results.
A later pooled analysis by Armstrong and colleagues (Journal of Foot and Ankle Research, 2020), restricted to studies published after 2007, reported five-year mortality of 30.5% for DFU, 29.0% for Charcot neuroarthropathy, 46.2% for minor amputation and 56.6% for major amputation. For context, the all-cancer pooled figure in the same analysis was 31%. The authors concluded that DFU and amputation behave as independent risk factors for early death rather than simply reflecting poor general health.
The most comprehensive meta-analysis to date, by Chen and colleagues (Diabetes, Obesity and Metabolism, 2022), pooled 34 studies including 124,376 participants from 16 countries. Estimated survival was 86.9% at one year, 66.9% at three years, 50.9% at five years and 23.1% at ten years.
Why Do Patients With Foot Ulcers Die?
The same meta-analysis identified cardiovascular disease as the leading cause of death, accounting for about 47% of deaths, followed by infection at about 25%. This pattern fits the biology: the atherosclerosis, chronic kidney disease and systemic inflammation that impair foot perfusion and healing also affect the heart, brain and kidneys.
Several comorbidities were associated with higher mortality in the pooled hazard-ratio analysis:
- Peripheral artery disease: hazard ratio (HR) 1.88
- Chronic kidney disease: HR 1.54
- End-stage renal disease: HR 3.59
- Prior cardiovascular disease: HR 1.45
- Amputation: HR 2.42
- Older age: HR 1.05 per additional year
Earlier work by Morbach and colleagues, summarized in the Jupiter review, illustrates the effect of vascular disease: five-year mortality was 58.8% in patients with peripheral vascular disease and 30.2% in those without.
Mortality After Amputation
Major amputation carries the highest risk. Systematic reviews by Thorud and colleagues (Journal of Foot and Ankle Surgery, 2016) reported five-year mortality after major amputation in patients with diabetes and peripheral vascular disease ranging from roughly 52% to 80%. Walking status appears to matter: in one cohort cited by those authors, five-year mortality was 30% in patients who regained ambulation after major amputation and 69% in those who did not.
Timing and outcome of healing also carry prognostic weight. In the Apelqvist cohort summarized by Jupiter and colleagues, five-year survival was 27% when an ulcer healed only after amputation, compared with 58% when it healed without amputation. Amputation therefore tends to mark a patient with more advanced disease, in addition to carrying its own physiological and functional burden.
Is Survival Improving?
There are encouraging signals. In a cohort summarized in the Jupiter review (Young and colleagues), five-year mortality fell from 48% in a 1995–1999 cohort to 26.8% in a 2001–2004 cohort, which the authors attributed in part to better cardiovascular risk management and organized foot care. However, estimates still differ widely between settings, and the available evidence is observational, so confounding by disease severity and comorbidity cannot be excluded.
Clinical Takeaways
A diabetic foot ulcer is associated with five-year mortality in the range of roughly 30% to 50%, comparable to or exceeding that of many cancers, and major amputation is associated with higher figures still. Most deaths are cardiovascular or infection-related, and peripheral artery disease, kidney disease and prior cardiovascular disease are the strongest identified predictors. The evidence supports viewing a foot ulcer as a prompt for broader assessment of cardiovascular, renal and vascular status, and not as an isolated local problem.
References
- Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. Journal of Foot and Ankle Research. 2020.
- Chen L, et al. Global mortality of diabetic foot ulcer: a systematic review and meta-analysis of observational studies. Diabetes, Obesity and Metabolism. 2022.
- Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients. I: From ulceration to death, a systematic review. International Wound Journal. 2016;13(5):892–903.
- Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. Journal of Foot and Ankle Surgery. 2016.
Comments
